Berlin Partner reports on ASC Oncology as a pioneer in modern cancer research and on the Reverse Clinical Engineering®, which makes advances in modern cancer research accessible to patients in the sense of personalized treatment.
EU Startup News is calling ASC Oncology one of the 15 Biotechnology Startups with biotech breakthroughs. The “reverse clinical engineering supports both patients and physicians, showcasing a unique approach in biotech health diagnostics and therapeutics.”
SelectScience talked to our CEO Dr Christian. Regenbrecht about bringing targeted tumor therapy to patients and the promising future of patient-derived tumor organoids.
berlin-buch.com reports about the collaboration of Maya Niethard, MD (Sarcoma Center Helios-Hospital Berlin Buch) and Christian Regenbrecht, PHD (ASC Oncology / Cellphenomics).
Dr. Christian Regenbrecht was a guest at the podcast “The Culture Club” and talked about 3D cell culture technologies, preclinical efficacy studies, and the changing healthcare landscape.
Dr. Regenbrecht speaks on the Youtube channel of the Rotary Club about the treatment of cancer and the Non For Profit Organization/Network “Scientists without Borders”.
Cancer does not stop at borders – and neither does an approach to personalized cancer therapy developed in Berlin. Reverse Clinical Engineering® is now available to oncologists and cancer patients in Saudi Arabia, the Middle East, and North Africa.
ASC Oncology proudly announces new partnership with Tamer Group Berlin, Germany (November, 01 2022) – Across borders, cancer is one of those diseases that is unpredictable, malignant and, despite high research efforts, not yet conquered. About 19.3 million people worldwide are diagnosed with cancer every year, and at the same time the prescribed chemotherapy fails […]
Knowing what works: Thanks to a new test procedure before the start of therapy, ASC Oncology can answer the crucial question posed by both patients and oncologists of how effective cancer drugs will be on each patient’s tumor.
Berlin, 01/27/2021 – In about half of the world’s cancer patients, the prescribed chemotherapy fails. With the Reverse Clinical EngineeringÒtest procedure, ASC Oncology addresses this challenge in cancer treatment and makes scientifically sound statements on how effective, or not, cancer drugs are likely to be on each patient’s individual tumor tissue. Outside the body, no […]
